Gordon H Guyatt, Andrew D Oxman, Victor Montori, Gunn Vist, Regina Kunz, Jan Brozek, Pablo Alonso-Coello, Ben Djulbegovic, David Atkins, Yngve Falck-Ytter, John W Williams, Joerg Meerpohl, Susan L Norris, Elie A Akl, Holger J Schünemann. J Clin Epidemiol 2011
Times Cited: 1032
Times Cited: 1032
Times Cited
Times Co-cited
Similarity
GRADE guidelines: 7. Rating the quality of evidence--inconsistency.
Gordon H Guyatt, Andrew D Oxman, Regina Kunz, James Woodcock, Jan Brozek, Mark Helfand, Pablo Alonso-Coello, Paul Glasziou, Roman Jaeschke, Elie A Akl,[...]. J Clin Epidemiol 2011
Gordon H Guyatt, Andrew D Oxman, Regina Kunz, James Woodcock, Jan Brozek, Mark Helfand, Pablo Alonso-Coello, Paul Glasziou, Roman Jaeschke, Elie A Akl,[...]. J Clin Epidemiol 2011
66
GRADE guidelines: 8. Rating the quality of evidence--indirectness.
Gordon H Guyatt, Andrew D Oxman, Regina Kunz, James Woodcock, Jan Brozek, Mark Helfand, Pablo Alonso-Coello, Yngve Falck-Ytter, Roman Jaeschke, Gunn Vist,[...]. J Clin Epidemiol 2011
Gordon H Guyatt, Andrew D Oxman, Regina Kunz, James Woodcock, Jan Brozek, Mark Helfand, Pablo Alonso-Coello, Yngve Falck-Ytter, Roman Jaeschke, Gunn Vist,[...]. J Clin Epidemiol 2011
62
GRADE guidelines 6. Rating the quality of evidence--imprecision.
Gordon H Guyatt, Andrew D Oxman, Regina Kunz, Jan Brozek, Pablo Alonso-Coello, David Rind, P J Devereaux, Victor M Montori, Bo Freyschuss, Gunn Vist,[...]. J Clin Epidemiol 2011
Gordon H Guyatt, Andrew D Oxman, Regina Kunz, Jan Brozek, Pablo Alonso-Coello, David Rind, P J Devereaux, Victor M Montori, Bo Freyschuss, Gunn Vist,[...]. J Clin Epidemiol 2011
61
GRADE guidelines: 4. Rating the quality of evidence--study limitations (risk of bias).
Gordon H Guyatt, Andrew D Oxman, Gunn Vist, Regina Kunz, Jan Brozek, Pablo Alonso-Coello, Victor Montori, Elie A Akl, Ben Djulbegovic, Yngve Falck-Ytter,[...]. J Clin Epidemiol 2011
Gordon H Guyatt, Andrew D Oxman, Gunn Vist, Regina Kunz, Jan Brozek, Pablo Alonso-Coello, Victor Montori, Elie A Akl, Ben Djulbegovic, Yngve Falck-Ytter,[...]. J Clin Epidemiol 2011
61
GRADE guidelines: 3. Rating the quality of evidence.
Howard Balshem, Mark Helfand, Holger J Schünemann, Andrew D Oxman, Regina Kunz, Jan Brozek, Gunn E Vist, Yngve Falck-Ytter, Joerg Meerpohl, Susan Norris,[...]. J Clin Epidemiol 2011
Howard Balshem, Mark Helfand, Holger J Schünemann, Andrew D Oxman, Regina Kunz, Jan Brozek, Gunn E Vist, Yngve Falck-Ytter, Joerg Meerpohl, Susan Norris,[...]. J Clin Epidemiol 2011
26
GRADE guidelines: 1. Introduction-GRADE evidence profiles and summary of findings tables.
Gordon Guyatt, Andrew D Oxman, Elie A Akl, Regina Kunz, Gunn Vist, Jan Brozek, Susan Norris, Yngve Falck-Ytter, Paul Glasziou, Hans DeBeer,[...]. J Clin Epidemiol 2011
Gordon Guyatt, Andrew D Oxman, Elie A Akl, Regina Kunz, Gunn Vist, Jan Brozek, Susan Norris, Yngve Falck-Ytter, Paul Glasziou, Hans DeBeer,[...]. J Clin Epidemiol 2011
24
GRADE: an emerging consensus on rating quality of evidence and strength of recommendations.
Gordon H Guyatt, Andrew D Oxman, Gunn E Vist, Regina Kunz, Yngve Falck-Ytter, Pablo Alonso-Coello, Holger J Schünemann. BMJ 2008
Gordon H Guyatt, Andrew D Oxman, Gunn E Vist, Regina Kunz, Yngve Falck-Ytter, Pablo Alonso-Coello, Holger J Schünemann. BMJ 2008
23
GRADE guidelines: 9. Rating up the quality of evidence.
Gordon H Guyatt, Andrew D Oxman, Shahnaz Sultan, Paul Glasziou, Elie A Akl, Pablo Alonso-Coello, David Atkins, Regina Kunz, Jan Brozek, Victor Montori,[...]. J Clin Epidemiol 2011
Gordon H Guyatt, Andrew D Oxman, Shahnaz Sultan, Paul Glasziou, Elie A Akl, Pablo Alonso-Coello, David Atkins, Regina Kunz, Jan Brozek, Victor Montori,[...]. J Clin Epidemiol 2011
18
RoB 2: a revised tool for assessing risk of bias in randomised trials.
Jonathan A C Sterne, Jelena Savović, Matthew J Page, Roy G Elbers, Natalie S Blencowe, Isabelle Boutron, Christopher J Cates, Hung-Yuan Cheng, Mark S Corbett, Sandra M Eldridge,[...]. BMJ 2019
Jonathan A C Sterne, Jelena Savović, Matthew J Page, Roy G Elbers, Natalie S Blencowe, Isabelle Boutron, Christopher J Cates, Hung-Yuan Cheng, Mark S Corbett, Sandra M Eldridge,[...]. BMJ 2019
17
Measuring inconsistency in meta-analyses.
Julian P T Higgins, Simon G Thompson, Jonathan J Deeks, Douglas G Altman. BMJ 2003
Julian P T Higgins, Simon G Thompson, Jonathan J Deeks, Douglas G Altman. BMJ 2003
15
The Cochrane Collaboration's tool for assessing risk of bias in randomised trials.
Julian P T Higgins, Douglas G Altman, Peter C Gøtzsche, Peter Jüni, David Moher, Andrew D Oxman, Jelena Savovic, Kenneth F Schulz, Laura Weeks, Jonathan A C Sterne. BMJ 2011
Julian P T Higgins, Douglas G Altman, Peter C Gøtzsche, Peter Jüni, David Moher, Andrew D Oxman, Jelena Savovic, Kenneth F Schulz, Laura Weeks, Jonathan A C Sterne. BMJ 2011
14
The PRISMA 2020 statement: an updated guideline for reporting systematic reviews.
Matthew J Page, Joanne E McKenzie, Patrick M Bossuyt, Isabelle Boutron, Tammy C Hoffmann, Cynthia D Mulrow, Larissa Shamseer, Jennifer M Tetzlaff, Elie A Akl, Sue E Brennan,[...]. BMJ 2021
Matthew J Page, Joanne E McKenzie, Patrick M Bossuyt, Isabelle Boutron, Tammy C Hoffmann, Cynthia D Mulrow, Larissa Shamseer, Jennifer M Tetzlaff, Elie A Akl, Sue E Brennan,[...]. BMJ 2021
14
Updated guidance for trusted systematic reviews: a new edition of the Cochrane Handbook for Systematic Reviews of Interventions.
Miranda Cumpston, Tianjing Li, Matthew J Page, Jacqueline Chandler, Vivian A Welch, Julian Pt Higgins, James Thomas. Cochrane Database Syst Rev 2019
Miranda Cumpston, Tianjing Li, Matthew J Page, Jacqueline Chandler, Vivian A Welch, Julian Pt Higgins, James Thomas. Cochrane Database Syst Rev 2019
12
ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions.
Jonathan Ac Sterne, Miguel A Hernán, Barnaby C Reeves, Jelena Savović, Nancy D Berkman, Meera Viswanathan, David Henry, Douglas G Altman, Mohammed T Ansari, Isabelle Boutron,[...]. BMJ 2016
Jonathan Ac Sterne, Miguel A Hernán, Barnaby C Reeves, Jelena Savović, Nancy D Berkman, Meera Viswanathan, David Henry, Douglas G Altman, Mohammed T Ansari, Isabelle Boutron,[...]. BMJ 2016
12
Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement.
David Moher, Alessandro Liberati, Jennifer Tetzlaff, Douglas G Altman. PLoS Med 2009
David Moher, Alessandro Liberati, Jennifer Tetzlaff, Douglas G Altman. PLoS Med 2009
10
The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration.
Alessandro Liberati, Douglas G Altman, Jennifer Tetzlaff, Cynthia Mulrow, Peter C Gøtzsche, John P A Ioannidis, Mike Clarke, P J Devereaux, Jos Kleijnen, David Moher. PLoS Med 2009
Alessandro Liberati, Douglas G Altman, Jennifer Tetzlaff, Cynthia Mulrow, Peter C Gøtzsche, John P A Ioannidis, Mike Clarke, P J Devereaux, Jos Kleijnen, David Moher. PLoS Med 2009
8
The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration.
Alessandro Liberati, Douglas G Altman, Jennifer Tetzlaff, Cynthia Mulrow, Peter C Gøtzsche, John P A Ioannidis, Mike Clarke, P J Devereaux, Jos Kleijnen, David Moher. J Clin Epidemiol 2009
Alessandro Liberati, Douglas G Altman, Jennifer Tetzlaff, Cynthia Mulrow, Peter C Gøtzsche, John P A Ioannidis, Mike Clarke, P J Devereaux, Jos Kleijnen, David Moher. J Clin Epidemiol 2009
8
GRADE guidelines 26: informative statements to communicate the findings of systematic reviews of interventions.
Nancy Santesso, Claire Glenton, Philipp Dahm, Paul Garner, Elie A Akl, Brian Alper, Romina Brignardello-Petersen, Alonso Carrasco-Labra, Hans De Beer, Monica Hultcrantz,[...]. J Clin Epidemiol 2020
Nancy Santesso, Claire Glenton, Philipp Dahm, Paul Garner, Elie A Akl, Brian Alper, Romina Brignardello-Petersen, Alonso Carrasco-Labra, Hans De Beer, Monica Hultcrantz,[...]. J Clin Epidemiol 2020
8
Recommendations for examining and interpreting funnel plot asymmetry in meta-analyses of randomised controlled trials.
Jonathan A C Sterne, Alex J Sutton, John P A Ioannidis, Norma Terrin, David R Jones, Joseph Lau, James Carpenter, Gerta Rücker, Roger M Harbord, Christopher H Schmid,[...]. BMJ 2011
Jonathan A C Sterne, Alex J Sutton, John P A Ioannidis, Norma Terrin, David R Jones, Joseph Lau, James Carpenter, Gerta Rücker, Roger M Harbord, Christopher H Schmid,[...]. BMJ 2011
8
A GRADE Working Group approach for rating the quality of treatment effect estimates from network meta-analysis.
Milo A Puhan, Holger J Schünemann, Mohammad Hassan Murad, Tianjing Li, Romina Brignardello-Petersen, Jasvinder A Singh, Alfons G Kessels, Gordon H Guyatt. BMJ 2014
Milo A Puhan, Holger J Schünemann, Mohammad Hassan Murad, Tianjing Li, Romina Brignardello-Petersen, Jasvinder A Singh, Alfons G Kessels, Gordon H Guyatt. BMJ 2014
8
GRADE guidelines: 2. Framing the question and deciding on important outcomes.
Gordon H Guyatt, Andrew D Oxman, Regina Kunz, David Atkins, Jan Brozek, Gunn Vist, Philip Alderson, Paul Glasziou, Yngve Falck-Ytter, Holger J Schünemann. J Clin Epidemiol 2011
Gordon H Guyatt, Andrew D Oxman, Regina Kunz, David Atkins, Jan Brozek, Gunn Vist, Philip Alderson, Paul Glasziou, Yngve Falck-Ytter, Holger J Schünemann. J Clin Epidemiol 2011
7
GRADE guidelines: 11. Making an overall rating of confidence in effect estimates for a single outcome and for all outcomes.
Gordon Guyatt, Andrew D Oxman, Shahnaz Sultan, Jan Brozek, Paul Glasziou, Pablo Alonso-Coello, David Atkins, Regina Kunz, Victor Montori, Roman Jaeschke,[...]. J Clin Epidemiol 2013
Gordon Guyatt, Andrew D Oxman, Shahnaz Sultan, Jan Brozek, Paul Glasziou, Pablo Alonso-Coello, David Atkins, Regina Kunz, Victor Montori, Roman Jaeschke,[...]. J Clin Epidemiol 2013
7
Advances in the GRADE approach to rate the certainty in estimates from a network meta-analysis.
Romina Brignardello-Petersen, Ashley Bonner, Paul E Alexander, Reed A Siemieniuk, Toshi A Furukawa, Bram Rochwerg, Glen S Hazlewood, Waleed Alhazzani, Reem A Mustafa, M Hassan Murad,[...]. J Clin Epidemiol 2018
Romina Brignardello-Petersen, Ashley Bonner, Paul E Alexander, Reed A Siemieniuk, Toshi A Furukawa, Bram Rochwerg, Glen S Hazlewood, Waleed Alhazzani, Reem A Mustafa, M Hassan Murad,[...]. J Clin Epidemiol 2018
7
GRADE guidelines: 12. Preparing summary of findings tables-binary outcomes.
Gordon H Guyatt, Andrew D Oxman, Nancy Santesso, Mark Helfand, Gunn Vist, Regina Kunz, Jan Brozek, Susan Norris, Joerg Meerpohl, Ben Djulbegovic,[...]. J Clin Epidemiol 2013
Gordon H Guyatt, Andrew D Oxman, Nancy Santesso, Mark Helfand, Gunn Vist, Regina Kunz, Jan Brozek, Susan Norris, Joerg Meerpohl, Ben Djulbegovic,[...]. J Clin Epidemiol 2013
6
6
Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement.
David Moher, Alessandro Liberati, Jennifer Tetzlaff, Douglas G Altman. Ann Intern Med 2009
David Moher, Alessandro Liberati, Jennifer Tetzlaff, Douglas G Altman. Ann Intern Med 2009
5
GRADE guidelines: a new series of articles in the Journal of Clinical Epidemiology.
Gordon H Guyatt, Andrew D Oxman, Holger J Schünemann, Peter Tugwell, Andre Knottnerus. J Clin Epidemiol 2011
Gordon H Guyatt, Andrew D Oxman, Holger J Schünemann, Peter Tugwell, Andre Knottnerus. J Clin Epidemiol 2011
5
Estimating the sample mean and standard deviation from the sample size, median, range and/or interquartile range.
Xiang Wan, Wenqian Wang, Jiming Liu, Tiejun Tong. BMC Med Res Methodol 2014
Xiang Wan, Wenqian Wang, Jiming Liu, Tiejun Tong. BMC Med Res Methodol 2014
5
GRADE guidelines: 13. Preparing summary of findings tables and evidence profiles-continuous outcomes.
Gordon H Guyatt, Kristian Thorlund, Andrew D Oxman, Stephen D Walter, Donald Patrick, Toshi A Furukawa, Bradley C Johnston, Paul Karanicolas, Elie A Akl, Gunn Vist,[...]. J Clin Epidemiol 2013
Gordon H Guyatt, Kristian Thorlund, Andrew D Oxman, Stephen D Walter, Donald Patrick, Toshi A Furukawa, Bradley C Johnston, Paul Karanicolas, Elie A Akl, Gunn Vist,[...]. J Clin Epidemiol 2013
5
The GRADE approach is reproducible in assessing the quality of evidence of quantitative evidence syntheses.
Reem A Mustafa, Nancy Santesso, Jan Brozek, Elie A Akl, Stephen D Walter, Geoff Norman, Mahan Kulasegaram, Robin Christensen, Gordon H Guyatt, Yngve Falck-Ytter,[...]. J Clin Epidemiol 2013
Reem A Mustafa, Nancy Santesso, Jan Brozek, Elie A Akl, Stephen D Walter, Geoff Norman, Mahan Kulasegaram, Robin Christensen, Gordon H Guyatt, Yngve Falck-Ytter,[...]. J Clin Epidemiol 2013
5
Grading quality of evidence and strength of recommendations.
David Atkins, Dana Best, Peter A Briss, Martin Eccles, Yngve Falck-Ytter, Signe Flottorp, Gordon H Guyatt, Robin T Harbour, Margaret C Haugh, David Henry,[...]. BMJ 2004
David Atkins, Dana Best, Peter A Briss, Martin Eccles, Yngve Falck-Ytter, Signe Flottorp, Gordon H Guyatt, Robin T Harbour, Margaret C Haugh, David Henry,[...]. BMJ 2004
5
GRADE approach to rate the certainty from a network meta-analysis: addressing incoherence.
Romina Brignardello-Petersen, Reem A Mustafa, Reed A C Siemieniuk, M Hassan Murad, Thomas Agoritsas, Ariel Izcovich, Holger J Schünemann, Gordon H Guyatt. J Clin Epidemiol 2019
Romina Brignardello-Petersen, Reem A Mustafa, Reed A C Siemieniuk, M Hassan Murad, Thomas Agoritsas, Ariel Izcovich, Holger J Schünemann, Gordon H Guyatt. J Clin Epidemiol 2019
10
GRADE approach to rate the certainty from a network meta-analysis: avoiding spurious judgments of imprecision in sparse networks.
Romina Brignardello-Petersen, M Hassan Murad, Stephen D Walter, Shelley McLeod, Alonso Carrasco-Labra, Bram Rochwerg, Holger J Schünemann, George Tomlinson, Gordon H Guyatt. J Clin Epidemiol 2019
Romina Brignardello-Petersen, M Hassan Murad, Stephen D Walter, Shelley McLeod, Alonso Carrasco-Labra, Bram Rochwerg, Holger J Schünemann, George Tomlinson, Gordon H Guyatt. J Clin Epidemiol 2019
7
AMSTAR 2: a critical appraisal tool for systematic reviews that include randomised or non-randomised studies of healthcare interventions, or both.
Beverley J Shea, Barnaby C Reeves, George Wells, Micere Thuku, Candyce Hamel, Julian Moran, David Moher, Peter Tugwell, Vivian Welch, Elizabeth Kristjansson,[...]. BMJ 2017
Beverley J Shea, Barnaby C Reeves, George Wells, Micere Thuku, Candyce Hamel, Julian Moran, David Moher, Peter Tugwell, Vivian Welch, Elizabeth Kristjansson,[...]. BMJ 2017
4
Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015 statement.
David Moher, Larissa Shamseer, Mike Clarke, Davina Ghersi, Alessandro Liberati, Mark Petticrew, Paul Shekelle, Lesley A Stewart. Syst Rev 2015
David Moher, Larissa Shamseer, Mike Clarke, Davina Ghersi, Alessandro Liberati, Mark Petticrew, Paul Shekelle, Lesley A Stewart. Syst Rev 2015
4
Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement.
David Moher, Alessandro Liberati, Jennifer Tetzlaff, Douglas G Altman. BMJ 2009
David Moher, Alessandro Liberati, Jennifer Tetzlaff, Douglas G Altman. BMJ 2009
4
Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group.
D F Stroup, J A Berlin, S C Morton, I Olkin, G D Williamson, D Rennie, D Moher, B J Becker, T A Sipe, S B Thacker. JAMA 2000
D F Stroup, J A Berlin, S C Morton, I Olkin, G D Williamson, D Rennie, D Moher, B J Becker, T A Sipe, S B Thacker. JAMA 2000
4
GRADE guidelines: 15. Going from evidence to recommendation-determinants of a recommendation's direction and strength.
Jeffrey C Andrews, Holger J Schünemann, Andrew D Oxman, Kevin Pottie, Joerg J Meerpohl, Pablo Alonso Coello, David Rind, Victor M Montori, Juan Pablo Brito, Susan Norris,[...]. J Clin Epidemiol 2013
Jeffrey C Andrews, Holger J Schünemann, Andrew D Oxman, Kevin Pottie, Joerg J Meerpohl, Pablo Alonso Coello, David Rind, Victor M Montori, Juan Pablo Brito, Susan Norris,[...]. J Clin Epidemiol 2013
4
GRADE guidelines: 14. Going from evidence to recommendations: the significance and presentation of recommendations.
Jeff Andrews, Gordon Guyatt, Andrew D Oxman, Phil Alderson, Philipp Dahm, Yngve Falck-Ytter, Mona Nasser, Joerg Meerpohl, Piet N Post, Regina Kunz,[...]. J Clin Epidemiol 2013
Jeff Andrews, Gordon Guyatt, Andrew D Oxman, Phil Alderson, Philipp Dahm, Yngve Falck-Ytter, Mona Nasser, Joerg Meerpohl, Piet N Post, Regina Kunz,[...]. J Clin Epidemiol 2013
4
GRADE guidelines: 18. How ROBINS-I and other tools to assess risk of bias in nonrandomized studies should be used to rate the certainty of a body of evidence.
Holger J Schünemann, Carlos Cuello, Elie A Akl, Reem A Mustafa, Jörg J Meerpohl, Kris Thayer, Rebecca L Morgan, Gerald Gartlehner, Regina Kunz, S Vittal Katikireddi,[...]. J Clin Epidemiol 2019
Holger J Schünemann, Carlos Cuello, Elie A Akl, Reem A Mustafa, Jörg J Meerpohl, Kris Thayer, Rebecca L Morgan, Gerald Gartlehner, Regina Kunz, S Vittal Katikireddi,[...]. J Clin Epidemiol 2019
4
Graphical tools for network meta-analysis in STATA.
Anna Chaimani, Julian P T Higgins, Dimitris Mavridis, Panagiota Spyridonos, Georgia Salanti. PLoS One 2013
Anna Chaimani, Julian P T Higgins, Dimitris Mavridis, Panagiota Spyridonos, Georgia Salanti. PLoS One 2013
4
GRADE approach to drawing conclusions from a network meta-analysis using a minimally contextualised framework.
Romina Brignardello-Petersen, Ivan D Florez, Ariel Izcovich, Nancy Santesso, Glen Hazlewood, Waleed Alhazanni, Juan José Yepes-Nuñez, George Tomlinson, Holger J Schünemann, Gordon H Guyatt. BMJ 2020
Romina Brignardello-Petersen, Ivan D Florez, Ariel Izcovich, Nancy Santesso, Glen Hazlewood, Waleed Alhazanni, Juan José Yepes-Nuñez, George Tomlinson, Holger J Schünemann, Gordon H Guyatt. BMJ 2020
7
GRADE guidelines 32: GRADE offers guidance on choosing targets of GRADE certainty of evidence ratings.
Linan Zeng, Romina Brignardello-Petersen, Monica Hultcrantz, Reed A C Siemieniuk, Nancy Santesso, Gregory Traversy, Ariel Izcovich, Behnam Sadeghirad, Paul E Alexander, Tahira Devji,[...]. J Clin Epidemiol 2021
Linan Zeng, Romina Brignardello-Petersen, Monica Hultcrantz, Reed A C Siemieniuk, Nancy Santesso, Gregory Traversy, Ariel Izcovich, Behnam Sadeghirad, Paul E Alexander, Tahira Devji,[...]. J Clin Epidemiol 2021
11
Bias in meta-analysis detected by a simple, graphical test.
M Egger, G Davey Smith, M Schneider, C Minder. BMJ 1997
M Egger, G Davey Smith, M Schneider, C Minder. BMJ 1997
4
Checking consistency in mixed treatment comparison meta-analysis.
S Dias, N J Welton, D M Caldwell, A E Ades. Stat Med 2010
S Dias, N J Welton, D M Caldwell, A E Ades. Stat Med 2010
4
Graphical methods and numerical summaries for presenting results from multiple-treatment meta-analysis: an overview and tutorial.
Georgia Salanti, A E Ades, John P A Ioannidis. J Clin Epidemiol 2011
Georgia Salanti, A E Ades, John P A Ioannidis. J Clin Epidemiol 2011
4
GRADE guidelines: 10. Considering resource use and rating the quality of economic evidence.
Massimo Brunetti, Ian Shemilt, Silvia Pregno, Luke Vale, Andrew D Oxman, Joanne Lord, Jane Sisk, Francis Ruiz, Suzanne Hill, Gordon H Guyatt,[...]. J Clin Epidemiol 2013
Massimo Brunetti, Ian Shemilt, Silvia Pregno, Luke Vale, Andrew D Oxman, Joanne Lord, Jane Sisk, Francis Ruiz, Suzanne Hill, Gordon H Guyatt,[...]. J Clin Epidemiol 2013
4
Rayyan-a web and mobile app for systematic reviews.
Mourad Ouzzani, Hossam Hammady, Zbys Fedorowicz, Ahmed Elmagarmid. Syst Rev 2016
Mourad Ouzzani, Hossam Hammady, Zbys Fedorowicz, Ahmed Elmagarmid. Syst Rev 2016
4
Development of the Instrument to assess the Credibility of Effect Modification Analyses (ICEMAN) in randomized controlled trials and meta-analyses.
Stefan Schandelmaier, Matthias Briel, Ravi Varadhan, Christopher H Schmid, Niveditha Devasenapathy, Rodney A Hayward, Joel Gagnier, Michael Borenstein, Geert J M G van der Heijden, Issa J Dahabreh,[...]. CMAJ 2020
Stefan Schandelmaier, Matthias Briel, Ravi Varadhan, Christopher H Schmid, Niveditha Devasenapathy, Rodney A Hayward, Joel Gagnier, Michael Borenstein, Geert J M G van der Heijden, Issa J Dahabreh,[...]. CMAJ 2020
4
Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.